Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -377,737 | -137,295 | -85,796 | -33,573 | -156,988 |
| Depreciation Amortization | 56 | 46 | 35 | 23 | 137 |
| Accounts payable and accrued liabilities | -10,043 | -11,159 | -9,205 | 2,882 | 11,740 |
| Other Working Capital | 951 | -7,364 | -3,700 | -8,858 | 25,431 |
| Other Operating Activity | 214,440 | 35,853 | 19,872 | 2,475 | 6 |
| Operating Cash Flow | $-172,333 | $-119,919 | $-78,794 | $-37,051 | $-119,674 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -216,868 | -153,504 | -198,547 | -86,256 | -30,421 |
| PPE Investments | -18 | -18 | -18 | -18 | -131 |
| Net Acquisitions | -35,000 | -5,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-251,886 | $-158,522 | $-198,565 | $-86,274 | $-30,552 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 75,000 | 75,000 | N/A | N/A | N/A |
| Common Stock Issued | 152,945 | 2,761 | 1,821 | 99 | 240,911 |
| Other Financing Activity | -12,665 | -3,324 | 0 | 0 | 172,047 |
| Financing Cash Flow | $215,280 | $74,437 | $1,821 | $99 | $412,958 |
| Exchange Rate Effect | -252 | -263 | -288 | -52 | 157 |
| Beginning Cash Position | 319,832 | 319,832 | 319,832 | 319,832 | 56,943 |
| End Cash Position | 110,641 | 115,565 | 44,006 | 196,554 | 319,832 |
| Net Cash Flow | $-209,191 | $-204,267 | $-275,826 | $-123,278 | $262,889 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172,333 | -119,919 | -78,794 | -37,051 | -119,674 |
| Capital Expenditure | -18 | -18 | -18 | -18 | -131 |
| Free Cash Flow | -172,351 | -119,937 | -78,812 | -37,069 | -119,805 |